KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Current Taxes (2016 - 2019)

Historic Current Taxes for Bristol Myers Squibb (BMY) over the last 11 years, with Q1 2019 value amounting to $525.0 million.

  • Bristol Myers Squibb's Current Taxes rose 7736.49% to $525.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $525.0 million, marking a year-over-year increase of 7736.49%. This contributed to the annual value of $398.0 million for FY2018, which is 7229.44% up from last year.
  • As of Q1 2019, Bristol Myers Squibb's Current Taxes stood at $525.0 million, which was up 7736.49% from $398.0 million recorded in Q4 2018.
  • Bristol Myers Squibb's 5-year Current Taxes high stood at $572.0 million for Q4 2015, and its period low was $98.0 million during Q2 2015.
  • In the last 5 years, Bristol Myers Squibb's Current Taxes had a median value of $291.0 million in 2017 and averaged $295.9 million.
  • As far as peak fluctuations go, Bristol Myers Squibb's Current Taxes soared by 11832.06% in 2015, and later plummeted by 7342.66% in 2016.
  • Bristol Myers Squibb's Current Taxes (Quarter) stood at $572.0 million in 2015, then tumbled by 73.43% to $152.0 million in 2016, then soared by 51.97% to $231.0 million in 2017, then soared by 72.29% to $398.0 million in 2018, then skyrocketed by 31.91% to $525.0 million in 2019.
  • Its Current Taxes stands at $525.0 million for Q1 2019, versus $398.0 million for Q4 2018 and $355.0 million for Q3 2018.